iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Evolution Wealth Advisors LLC

Evolution Wealth Advisors LLC lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 23,688 shares of the financial services provider’s stock after buying an additional 1,156 shares during the quarter. Evolution Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $3,132,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. BNP Paribas Financial Markets raised its stake in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its stake in iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the 4th quarter valued at about $18,476,000. Aristides Capital LLC acquired a new position in iShares Biotechnology ETF in the 2nd quarter valued at about $9,180,000. Finally, Sanctuary Advisors LLC acquired a new position in iShares Biotechnology ETF in the 2nd quarter valued at about $8,118,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $136.29 on Thursday. The firm has a 50-day moving average price of $136.00 and a 200 day moving average price of $141.81. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.